BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 16764879)

  • 21. Should we be using misoprostol to prevent postpartum haemorrhage?
    Pract Midwife; 2013 May; 16(5):9. PubMed ID: 23789247
    [No Abstract]   [Full Text] [Related]  

  • 22. Profound Hyperthermia After Postpartum Rectal Misoprostol Administration.
    Kaiser J; Royer PA
    Obstet Gynecol; 2016 Jun; 127(6):1067-1069. PubMed ID: 27159749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of misoprostol in third stage of labour.
    Shannon C; Winikoff B
    Lancet; 2002 Feb; 359(9307):709; author reply 709-10. PubMed ID: 11879893
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparative study between rectally administered misoprostol as a prophylaxis versus conventional intramuscular oxytocin in post partum hemorrhage.
    Haque N; Bilkis L; Haque N; Bari MS; Haque S
    Mymensingh Med J; 2009 Jan; 18(1 Suppl):S40-44. PubMed ID: 19377430
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of rectal misoprostol as active pharmacological management of the third stage of labor.
    Diab KM; Ramy AR; Yehia MA
    J Obstet Gynaecol Res; 1999 Oct; 25(5):327-32. PubMed ID: 10533327
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of misoprostol in third stage of labour.
    Khan R; Sharma S
    Lancet; 2002 Feb; 359(9307):708-9; author reply 709-10. PubMed ID: 11879892
    [No Abstract]   [Full Text] [Related]  

  • 27. Prostaglandins in the prevention and management of postpartum haemorrhage.
    Sharma S; El-Refaey H
    Best Pract Res Clin Obstet Gynaecol; 2003 Oct; 17(5):811-23. PubMed ID: 12972016
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A double-blind randomized controlled trial of oral misoprostol and intramuscular syntometrine in the management of the third stage of labor.
    Mahajan NN; Mahajan K; Soni R
    Gynecol Obstet Invest; 2007; 64(2):82; author reply 83. PubMed ID: 17308389
    [No Abstract]   [Full Text] [Related]  

  • 29. Oral misoprostol for prevention of postpartum hemorrhage by paramedical workers in India.
    Chandhiok N; Dhillon BS; Datey S; Mathur A; Saxena NC
    Int J Gynaecol Obstet; 2006 Feb; 92(2):170-5. PubMed ID: 16371228
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of sublingual misoprostol, intravenous oxytocin, and intravenous methylergometrine in active management of the third stage of labor.
    Singh G; Radhakrishnan G; Guleria K
    Int J Gynaecol Obstet; 2009 Nov; 107(2):130-4. PubMed ID: 19628206
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral misoprostol versus oxytocin in the management of third stage of labour.
    Aziz S; Kazi S; Haq G; Soomro N
    J Pak Med Assoc; 2014 Apr; 64(4):428-32. PubMed ID: 24864638
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adjunctive rectal misoprostol versus oxytocin infusion for prevention of postpartum hemorrhage in women at risk: a randomized controlled trial.
    Badejoko OO; Ijarotimi AO; Awowole IO; Loto OM; Badejoko BO; Olaiya DS; Fatusi AO; Kuti O; Orji EO; Ogunniyi SO
    J Obstet Gynaecol Res; 2012 Nov; 38(11):1294-301. PubMed ID: 22612662
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Misoprostol for prevention and treatment of postpartum hemorrhage: what do we know? What is next?
    Raghavan S; Abbas D; Winikoff B
    Int J Gynaecol Obstet; 2012 Oct; 119 Suppl 1():S35-8. PubMed ID: 22883912
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Misoprostol for third stage of labour.
    el-Refaey H; O'Brien P; Morafa W; Walder J; Rodeck C
    Lancet; 1996 May; 347(9010):1257. PubMed ID: 8622464
    [No Abstract]   [Full Text] [Related]  

  • 35. Misoprostol for the prevention and treatment of postpartum hemorrhage.
    Sheldon WR; Blum J; Durocher J; Winikoff B
    Expert Opin Investig Drugs; 2012 Feb; 21(2):235-50. PubMed ID: 22233426
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Administration of 400 μg of misoprostol to augment routine active management of the third stage of labor.
    Hofmeyr GJ; Fawole B; Mugerwa K; Godi NP; Blignaut Q; Mangesi L; Singata M; Brady L; Blum J
    Int J Gynaecol Obstet; 2011 Feb; 112(2):98-102. PubMed ID: 21130990
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sublingual misoprostol versus intramuscular oxytocin for prevention of postpartum hemorrhage in low-risk women.
    Chaudhuri P; Biswas J; Mandal A
    Int J Gynaecol Obstet; 2012 Feb; 116(2):138-42. PubMed ID: 22100204
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of misoprostol in third stage of labour.
    El-ReFaey H
    Lancet; 2002 Feb; 359(9307):707-8; discussion 709-10. PubMed ID: 11879890
    [No Abstract]   [Full Text] [Related]  

  • 39. Questions raised over use of misoprostol to prevent postpartum haemorrhage in poor countries.
    Torjesen I
    BMJ; 2012 Aug; 345():e5715. PubMed ID: 22932982
    [No Abstract]   [Full Text] [Related]  

  • 40. [Rectal administration of misoprostol for delivery induced hemorrhage. Preliminary study].
    Shojai R; Piéchon L; d'Ercole C; Boubli L; Pontiès JE
    J Gynecol Obstet Biol Reprod (Paris); 2001 Oct; 30(6):572-5. PubMed ID: 11883024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.